By aligning lifestyle support with medical therapy, patients see not only better resultsbut more sustainable ones
10.1007/s00204-017-2036-4 Arch
Bridge program NovoCare self-pay program: approximately $199 per month for starting doses (0.25/0.5 mg, first two fills through December 31, 2026), then approximately $349 per month for standard injection doses
Many patients see accelerated weekly weight loss as their dose increases, because higher doses strengthen appetite suppression and metabolic effects
Jacques PF, Hartz SC, Chylack LT, McGandy RB, Sadowski JA
Currently, there are no approved targeted therapies for LVEF-preserved heart failure associated with obesity